-
JAMA Psychiatry
Original Investigation
May 1, 2022
Joshua E. J. Buckman, PhD; Rob Saunders, PhD; Joshua Stott, PhD; Zachary D. Cohen, PhD; Laura-Louise Arundell, MSc; Thalia C. Eley, PhD; Steven D. Hollon, PhD; Tony Kendrick, MD; Gareth Ambler, PhD; Edward Watkins, PhD; Simon Gilbody, PhD; David Kessler, MD; Nicola Wiles, PhD; David Richards, PhD; Sally Brabyn, MSc; Elizabeth Littlewood, PhD; Robert J. DeRubeis, PhD; Glyn Lewis, PhD; Stephen Pilling, PhD
open access
JAMA Psychiatry. 2022; 79(5):406-416. 10.1001/jamapsychiatry.2022.0100
This systematic review and meta-analysis investigates the socioeconomic factors associated with depression treatment outcome regardless of treatment type.
-
JAMA Psychiatry
Original Investigation
March 1, 2020
Robert J. DeRubeis, PhD; John Zajecka, MD; Richard C. Shelton, MD; Jay D. Amsterdam, MD; Jan Fawcett, MD; Colin Xu, MA; Paula R. Young, PhD; Robert Gallop, PhD; Steven D. Hollon, PhD
free access
JAMA Psychiatry. 2020; 77(3):237-245. 10.1001/jamapsychiatry.2019.3900
This phase 2 randomized clinical trial investigates the effect of treatment with cognitive behavioral therapy, administered with antidepressant medication, on recurrence prevention when medication treatment is maintained or withdrawn after recovery in adults with major depressive disorder.
-
JAMA Psychiatry
Comment & Response
June 1, 2016
Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Jan Fawcett, MD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; John Zajecka, MD; Paula R. Young, PhD; Robert Gallop, PhD
free access
JAMA Psychiatry. 2016; 73(6):639-640. 10.1001/jamapsychiatry.2016.0756
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164
-
JAMA Psychiatry
Original Investigation
November 1, 2015
David A. Brent, MD; Steven M. Brunwasser, PhD; Steven D. Hollon, PhD; V. Robin Weersing, PhD; Gregory N. Clarke, PhD; John F. Dickerson, PhD; William R. Beardslee, MD; Tracy R. G. Gladstone, PhD; Giovanna Porta, MS; Frances L. Lynch, PhD; Satish Iyengar, PhD; Judy Garber, PhD
free access
JAMA Psychiatry. 2015; 72(11):1110-1118. 10.1001/jamapsychiatry.2015.1559
This randomized clinical trial determines whether a cognitive-behavioral prevention program can reduce the incidence of depressive episodes, increase depression-free days, and improve developmental competence 6 years after implementation among at-risk adolescents.
-
JAMA Psychiatry
Original Investigation
Meta-analysis
November 1, 2015
Erica S. Weitz, MA; Steven D. Hollon, PhD; Jos Twisk, PhD; Annemieke van Straten, PhD; Marcus J. H. Huibers, PhD; Daniel David, PhD; Robert J. DeRubeis, PhD; Sona Dimidjian, PhD; Boadie W. Dunlop, MD, MS; Ioana A. Cristea, PhD; Mahbobeh Faramarzi, PhD; Ulrich Hegerl, MD, PhD; Robin B. Jarrett, PhD; Farzan Kheirkhah, MD; Sidney H. Kennedy, MD; Roland Mergl, PhD; Jeanne Miranda, PhD; David C. Mohr, PhD; A. John Rush, MD; Zindel V. Segal, PhD; Juned Siddique, DrPH; Anne D. Simons, PhD; Jeffrey R. Vittengl, PhD; Pim Cuijpers, PhD
free access
JAMA Psychiatry. 2015; 72(11):1102-1109. 10.1001/jamapsychiatry.2015.1516
This meta-analysis examines baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy and antidepressant medication.
-
JAMA Psychiatry
Original Investigation
October 1, 2014
Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Jan Fawcett, MD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; John Zajecka, MD; Paula R. Young, PhD; Robert Gallop, PhD
free access
JAMA Psychiatry. 2014; 71(10):1157-1164. 10.1001/jamapsychiatry.2014.1054
Hollon et al determine the effects of combining cognitive therapy with antidepressant medications vs antidepressant medications alone on remission and recovery in major depressive disorder. See the editorial by Thase.
-
JAMA Psychiatry
Original Investigation
November 1, 2013
William R. Beardslee, MD; David A. Brent, MD; V. Robin Weersing, PhD; Gregory N. Clarke, PhD; Giovanna Porta, MS; Steven D. Hollon, PhD; Tracy R. G. Gladstone, PhD; Robert Gallop, PhD; Frances L. Lynch, PhD; Satish Iyengar, PhD; Lynn DeBar, PhD; Judy Garber, PhD
free access
JAMA Psychiatry. 2013; 70(11):1161-1170. 10.1001/jamapsychiatry.2013.295
Beardslee et al determine whether the positive effects of a group cognitive-behavioral prevention (CBP) program extended to longer-term (multiyear) follow-up.
-
JAMA
Review
January 6, 2010
Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Sona Dimidjian, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Jan Fawcett, MD
JAMA. 2010; 303(1):47-53. 10.1001/jama.2009.1943
-
JAMA Psychiatry
Original Article
December 1, 2009
Tony Z. Tang, PhD; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Jay Amsterdam, MD; Richard Shelton, MD; Benjamin Schalet, MA
free access
Arch Gen Psychiatry. 2009; 66(12):1322-1330. 10.1001/archgenpsychiatry.2009.166
-
JAMA
Original Contribution
June 3, 2009
Judy Garber, PhD; Gregory N. Clarke, PhD; V. Robin Weersing, PhD; William R. Beardslee, MD; David A. Brent, MD; Tracy R. G. Gladstone, PhD; Lynn L. DeBar, PhD; Frances L. Lynch, PhD; Eugene D’Angelo, PhD; Steven D. Hollon, PhD; Wael Shamseddeen, MD, MPH; Satish Iyengar, PhD
free access
JAMA. 2009; 301(21):2215-2224. 10.1001/jama.2009.788
-
JAMA Psychiatry
Original Article
April 1, 2005
Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Richard C. Shelton, MD; Jay D. Amsterdam, MD; Ronald M. Salomon, MD; John P. O’Reardon, MD; Margaret L. Lovett, MEd; Paula R. Young, PhD; Kirsten L. Haman, PhD; Brent B. Freeman, BA; Robert Gallop, PhD
free access
Arch Gen Psychiatry. 2005; 62(4):417-422. 10.1001/archpsyc.62.4.417
-
JAMA Psychiatry
Original Article
April 1, 2005
Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Paula R. Young, PhD; Ronald M. Salomon, MD; John P. O’Reardon, MD; Margaret L. Lovett, MEd; Madeline M. Gladis, PhD; Laurel L. Brown, PhD; Robert Gallop, PhD
free access
Arch Gen Psychiatry. 2005; 62(4):409-416. 10.1001/archpsyc.62.4.409
-
JAMA Psychiatry
Article
October 1, 1992
Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Mark D. Evans, PhD; Marlin J. Wiemer, PhD; Michael J. Garvey, MD; William M. Grove, PhD; Vicente B. Tuason, MD, FRCPC
Arch Gen Psychiatry. 1992; 49(10):774-781. 10.1001/archpsyc.1992.01820100018004
-
JAMA Psychiatry
Article
October 1, 1992
Mark D. Evans, PhD; Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Joan M. Piasecki, PhD; William M. Grove, PhD; Michael J. Garvey, MD; Vicente B. Tuason, MD, FRCPC
Arch Gen Psychiatry. 1992; 49(10):802-808. 10.1001/archpsyc.1992.01820100046009
-
JAMA Psychiatry
Article
February 1, 1985
Aaron T. Beck, MD; Steven D. Hollon, PhD; Jeffrey E. Young, PhD; Richard C. Bedrosian, PhD; Donald Budenz
Arch Gen Psychiatry. 1985; 42(2):142-148. 10.1001/archpsyc.1985.01790250036005
-
JAMA Psychiatry
Article
January 1, 1981
Maria Kovacs, PhD; A. John Rush, MD; Aaron T. Beck, MD; Steven D. Hollon, PhD
Arch Gen Psychiatry. 1981; 38(1):33-39. 10.1001/archpsyc.1981.01780260035003